Compare HCA Health Inc (HCA) vs Raytheon Technologies Corp (RTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Raytheon Technologies Corp — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Raytheon Technologies Corp trades at $185.97 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 2.6× HCA Health Inc's market cap, and Raytheon Technologies Corp pays the higher dividend (1.58%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Raytheon Technologies Corp for 77 Days on average.
| HCA | RTX | |
|---|---|---|
Market Cap | $96.35B | $248.42B |
Volume | 1,079,453 | 4,380,368 |
Sector | Health | Industrials |
52-Week High | $545.13 | $225.49 |
52-Week Low | $361.32 | $157.00 |
Typical Hold Time | 76 Days | 77 Days |
Enterprise Value | $146.88B | $278.97B |
Dividend Yield | 0.7% | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
RTX trades at $184.32, up 2.25% with strong earnings momentum as Q1 and Q2 2026 results beat expectations. The stock shows bearish technical signals but benefits from a $289 billion backlog and rising defense spending. Revenue grew to $88.6 billion in 2025 with net income of $6.73 billion, while analyst consensus remains bullish with a $236.27 price target.
Outlook is positive given defense budget tailwinds and operational execution, though technical weakness and debt levels pose risks. The company's dividend and backlog provide stability, but investors should monitor geopolitical impacts and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →
